Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer" [Transl Oncol 12 (8) (2019) 1038-1044].
Meltzer S, Bjørnetrø T, Lyckander LG, Flatmark K, Dueland S, Samiappan R, Johansen C, Kalanxhi E, Ree AH, Redalen KR. Meltzer S, et al. Among authors: bjornetro t. Transl Oncol. 2020 Jan;13(1):122-124. doi: 10.1016/j.tranon.2019.09.005. Transl Oncol. 2020. PMID: 31843135 Free PMC article. No abstract available.
Uptake of circulating extracellular vesicles from rectal cancer patients and differential responses by human monocyte cultures.
Bjørnetrø T, Steffensen LA, Vestad B, Brusletto BS, Olstad OK, Trøseid AM, Aass HCD, Haug KBF, Llorente A, Bøe SO, Lång A, Samiappan R, Redalen KR, Øvstebø R, Ree AH. Bjørnetrø T, et al. FEBS Open Bio. 2021 Mar;11(3):724-740. doi: 10.1002/2211-5463.13098. Epub 2021 Feb 8. FEBS Open Bio. 2021. PMID: 33512765 Free PMC article.
The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression.
Bousquet PA, Meltzer S, Fuglestad AJ, Lüders T, Esbensen Y, Juul HV, Johansen C, Lyckander LG, Bjørnetrø T, Inderberg EM, Kersten C, Redalen KR, Ree AH. Bousquet PA, et al. Among authors: bjornetro t. Clin Transl Oncol. 2022 Jun;24(6):1157-1167. doi: 10.1007/s12094-021-02756-w. Epub 2021 Dec 27. Clin Transl Oncol. 2022. PMID: 34961902 Free PMC article.
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B. Jørgensen SF, et al. Among authors: bjornetro t. Sci Rep. 2019 Jan 17;9(1):167. doi: 10.1038/s41598-018-35367-7. Sci Rep. 2019. PMID: 30655568 Free PMC article. Retracted. Clinical Trial.
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial.
Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S. Ree AH, et al. Among authors: bjornetro t. Br J Cancer. 2024 Apr 25. doi: 10.1038/s41416-024-02696-6. Online ahead of print. Br J Cancer. 2024. PMID: 38664577
Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B. Jørgensen SF, et al. Among authors: bjornetro t. Sci Rep. 2024 Feb 14;14(1):3704. doi: 10.1038/s41598-024-54117-6. Sci Rep. 2024. PMID: 38355714 Free PMC article. No abstract available.